ID   NCE-G 130
AC   CVCL_N747
SY   NCE G 130; NCE-G130; G-130; G130; NeuroChirurgie Eppendorf-Glioma 130
DR   EFO; EFO_0006402
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472657
DR   EGA; EGAS00001000610
DR   IARC_TP53; 21614
DR   IARC_TP53; 23564
DR   PharmacoDB; G130_384_2019
DR   Wikidata; Q54907661
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=15816541;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*11:01,29:01; B*07:02,39:06; C*07:02,15:05 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (PubMed=8253536; PubMed=15816541).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12,18
ST   D21S11: 27,29
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 7,10
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 12
ST   Penta E: 5,7
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 18
//
RX   DOI=10.1007/0-306-46861-1_11;
RA   Ali-Osman F.;
RT   "Brain tumors.";
RL   (In) Human cell culture. Vol. 2. Cancer Cell Lines part 2; Masters J.R.W., Palsson B.O. (eds.); pp.167-184; Kluwer Academic Publishers; New York (1999).
//
RX   PubMed=8253536; DOI=10.1002/ijc.2910550618;
RA   Anker L., Ohgaki H., Ludeke B.I., Herrmann H.-D., Kleihues P.,
RA   Westphal M.;
RT   "p53 protein accumulation and gene mutations in human glioma cell
RT   lines.";
RL   Int. J. Cancer 55:982-987(1993).
//
RX   PubMed=8289093; DOI=10.1007/BF01324703;
RA   Hamel W., Westphal M., Shepard H.M.;
RT   "Loss in expression of the retinoblastoma gene product in human
RT   gliomas is associated with advanced disease.";
RL   J. Neurooncol. 16:159-165(1993).
//
RX   PubMed=15816541;
RA   Kim E.L., Yoshizato K., Kluwe L., Meissner H., Warnecke G., Zapf S.,
RA   Westphal M., Deppert W., Giese A.;
RT   "Comparative assessment of the functional p53 status in glioma
RT   cells.";
RL   Anticancer Res. 25:213-224(2005).
//
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S.,
RA   Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G.,
RA   Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J.,
RA   Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L.,
RA   Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J.,
RA   Settleman J., Seshagiri S., Zhang Z.-M.;
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5;
RA   Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P.,
RA   Loewer M., Sahin U., Castle J.C.;
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//